Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Mayo Clinic in Rochester

Mayo Clinic in Rochester in Rochester, Minnesota, United States is listed as a site for 1,652 registered clinical trials, 687 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,652
Ongoing 687

This page covers the site record Mayo Clinic in Rochester in Rochester, Minnesota, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Mayo Clinic in Rochester report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,652 trials counted.

  • Phase 1 180 trials
  • Phase 1/2 53 trials
  • Phase 2 310 trials
  • Phase 2/3 41 trials
  • Phase 3 207 trials
  • Phase 4 78 trials
  • Not applicable 525 trials
  • Observational 255 trials
  • Expanded access 3 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 687 trials
  • Completed 736 trials
  • Terminated 213 trials
  • Other 16 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 148

2000: 1 trials (Observational 1) 2001: 1 trials (Phase 3 1) 2002: 1 trials (Phase 1 1) 2003: 2 trials (Phase 3 2) 2004: 4 trials (Phase 3 3, Phase 2 1) 2005: 4 trials (Phase 3 4) 2006: 6 trials (Observational 1, Phase 3 4, Phase 2 1) 2007: 8 trials (Phase 3 8) 2008: 6 trials (Phase 3 4, Phase 2 1, Phase 1 1) 2009: 23 trials (Observational 2, Not applicable 3, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 2, Phase 1/2 2, Phase 1 1) 2010: 32 trials (Observational 6, Not applicable 5, Phase 4 3, Phase 3 7, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 3) 2011: 39 trials (Observational 7, Not applicable 11, Phase 4 2, Phase 3 6, Phase 2/3 3, Phase 2 3, Phase 1/2 1, Phase 1 6) 2012: 49 trials (Other 1, Observational 1, Not applicable 14, Phase 4 4, Phase 3 10, Phase 2 10, Phase 1/2 2, Phase 1 7) 2013: 62 trials (Observational 6, Not applicable 20, Phase 4 2, Phase 3 3, Phase 2/3 2, Phase 2 13, Phase 1/2 1, Phase 1 15) 2014: 80 trials (Observational 9, Not applicable 19, Phase 4 5, Phase 3 11, Phase 2/3 6, Phase 2 9, Phase 1/2 6, Phase 1 15) 2015: 79 trials (Observational 10, Not applicable 31, Phase 4 5, Phase 3 10, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 7) 2016: 101 trials (Observational 12, Not applicable 37, Phase 4 2, Phase 3 8, Phase 2/3 3, Phase 2 18, Phase 1/2 8, Phase 1 13) 2017: 131 trials (Observational 14, Not applicable 49, Phase 4 3, Phase 3 14, Phase 2/3 2, Phase 2 30, Phase 1/2 2, Phase 1 17) 2018: 127 trials (Observational 13, Not applicable 47, Phase 4 6, Phase 3 13, Phase 2/3 2, Phase 2 26, Phase 1/2 7, Phase 1 13) 2019: 131 trials (Observational 26, Not applicable 38, Phase 4 6, Phase 3 19, Phase 2/3 4, Phase 2 22, Phase 1/2 3, Phase 1 13) 2020: 121 trials (Observational 17, Not applicable 44, Phase 4 5, Phase 3 10, Phase 2/3 3, Phase 2 30, Phase 1/2 1, Phase 1 11) 2021: 148 trials (Observational 30, Not applicable 54, Phase 4 6, Phase 3 11, Phase 2/3 3, Phase 2 25, Phase 1/2 1, Phase 1 18) 2022: 96 trials (Observational 21, Not applicable 26, Phase 4 6, Phase 3 9, Phase 2/3 3, Phase 2 16, Phase 1/2 8, Phase 1 7) 2023: 100 trials (Observational 21, Not applicable 24, Phase 4 1, Phase 3 11, Phase 2/3 3, Phase 2 29, Phase 1/2 3, Phase 1 8) 2024: 103 trials (Observational 25, Not applicable 28, Phase 4 4, Phase 3 11, Phase 2 24, Phase 1 11) 2025: 112 trials (Observational 16, Not applicable 43, Phase 4 10, Phase 3 16, Phase 2/3 1, Phase 2 16, Phase 1/2 1, Phase 1 9)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 79
2025 112
2024 103
2023 100
2022 96
2021 148
2020 121
2019 131
2018 127
2017 131

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,652 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 19 lead sponsors.

Start your 14-day trial Email me all 19 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 645 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF